Cellular senescence, a mechanism employed by cells for thwarting proliferation, has shown to play an important role in protecting cells against cancer development in recent experimental observations, indicating that a deeper understanding of the cellular senescence pathway can help exploit its capacity for more effective cancer treatment. Furthermore, some experimental evidence points out that inhibition of CDK2 or Skp2 can be the critical trigger for cellular senescence. However, no mathematical model has been developed to highlight cellular senescence until now. In this study, we first implement a mathematical model of G1/S transition involving the DNA-damage pathway to highlight cellular senescence by lowering the critical trigger-CDK2. For this, we focus on the behaviour of two important proteins (E2F and CycE) for several reduced CDK2 levels under two DNA-damage conditions by calculating the probability (β) of DNA-damaged cells passing the G1/S. Our recently published results from the same model indicated that a large percentage of damaged cells pass G1/S under normal CDK2 levels, reaching β values of up to 65% under high level of DNA damage. The current study reveals that reduced CDK2 levels can significantly lower the percentage of damaged cells passing the G1/S; in particular, 50% reduction in CDK2 achieves 65% reduction in the passage of damaged cells. Furthermore, the model analyses the relationship between CDK2 and its CKIs in search of other effective ways to bring forward cellular senescence. Results show that the degradation rate of p21 and initial concentration of p27 can be effectively used to lower the senescence threshold. Specifically, p27 is the most effective, followed by CDK2 and p21. However, the combined effect of CDK2 and CKIs is dramatic with CDK2/p27 combination almost totally arresting the passage of damaged cells.
4 in cancerous cells. All these CDKs are important proteins to mediate the initiation of G1 phase and control the G1/S transition in the cell cycle. Furthermore, senescenceinducing stressors inhibit the activity of CDKs by controlling their inhibitory proteins (called CDK inhibitory kinases or CKIs), which include p21, p27 and p16 7, 8 .
Furthermore, Skp2 inhibition might be critical to lower the bar for senescence in oncogenically primed cells based on recent studies 2, 4, 5 . Skp2 can mediate the degradation of some CKIs, such as p21 and p27, and Skp2 inhibition can increase the expression of CKIs in the cell cycle, which also results in inhibiting the activity of CDK2s.
Although there is some experimental evidence pointing out that the inhibition of CDK2 or Skp2 can be the critical trigger for senescence, currently, there aren't any mathematical models developed to highlight the cellular senescence under DNA damage conditions. Senescence in this respect leads to an exciting question: Can a mathematical model highlight the cellular senescence and formulate scenarios for adjusting the threshold for senescence to evaluate its efficacy and outcomes? The purpose of this paper is to elucidate such an approach based on a mathematical model of G1/S transition pathway incorporating DNA-damage signal transduction; more specifically, we address the possibility of lowering the probability of a DNA-damaged cell passing as a healthy cell in the G1/S phase transition in response to lowering the threshold for senescence. Meanwhile, we also evaluate the relationship between CDK2 and its CKIs under different DNA damage situations in search of alternative approaches to lowering the senescence bar through these relationships in search of the most effective means of bringing senescence forward.
Model description
The latest mathematical model of the G1/S phase transition was published in 2008 by
Iwamoto et al. 9 , which simulates the G1/S transition incorporating the DNA damage signal transduction pathway. In this mathematical model, there are 28 ordinary differential equations with 75 kinetic parameters, which display interactions among the chemical species (for instance, E2F, CycE, CycA, CDK2, CDK4/6, p21, p27, p16, p53, Mdm2 and so on) in the G1/S transition integrating DNA damage signal (See Fig.1 ). Notably, all proteins crucial for triggering senescence are involved in the G1/S transition.
In our earlier work 3 , we evaluate the probability (β) of a DNA-damaged cell passing as a healthy cell in the G1/S phase transition in the presence of various levels of perturbation in the key kinetic parameters associated with the model. In order to achieve this, three important steps were followed: 1) we first decided on the important biomarkers for the G1/S transitions and selected E2F respectively.); 2) we then calculated the probability density function (PDF) of the peak time (PT) of the two biomarkers in response to various levels of perturbations to the important kinetic parameters through a Global Sensitivity Analysis (GSA) where these parameters are varied simultaneously; 3) based on the PDF of PT from GSA, we computed Type II error or power (β) using statistical hypothesis testing, where the type II error in this case indicates the probability of a damaged cell wrongly passing as a healthy cell. The details of the procedure and results can be found in Ling et al. 3 and the relevant results extracted from the paper are shown in Table 1 Table 2 shows the probability β of damaged cells passing G1/S checkpoint based on the PDF of PT of biomarker E2F under two different DNA-damage conditions for three reduced CDK2 levels: -10%, -30% and -50%, respectively. Table 3 displays the value of β for the three decreased CDK2 levels for CycE under the two DNAdamage conditions. According to the results from the behaviour of E2F and CycE under reduced and normal CDK2 levels, the probability of a damaged cell passing G1/S have decreased with inhibiting activity of CDK2; more importantly, there is a significant decrease in β based on both E2F and CycE when the CDK2 level is reduced to 50% of the normal level.
According to became more sensitized to cellular senescence under the oncogenic stress caused by
Myc oncogene or oncoprotein. Thus, our model supports the biological findings related to senescence; more importantly, it reveals the effect of reducing CDK2 levels in terms of the reduction of the percentage of damaged cells passing the G1/S checkpoint.
Effectiveness of CKIs in lowering the bar for senescence
Here, we investigate the behaviour of CKIs in response to reduced CDK2 levels, by reducing CDK2 in three different levels under two different DNA damage conditions, for example, CDK2-10%, CDK2-30% and CDK2-50%, respectively. Analytical results show that the change of CDK2 has littler or no effect on p16 and p27 at both low-level and high-level DNA damage. The reason is that most p27 molecules bind to
CycD/CDK4/6 complex at the beginning of G1 phase and only few p27 molecules bind to CycE/CDK2-P complex near the G1/S transition. However, the variation of CDK2 has a significant effect on p21 level in these two DNA damage situations. In the event of DNA damage, p21 is activated by p53 resulting in a dramatic effect on its concentration as required for promoting its binding to CycE/CDK2-P complex for arresting cell cycle. Fig.2 shows the behaviour of p21 for four levels of CDK2 under low-and high-level DNA damage as well as p21 behaviour for healthy cells. It shows that p21 level under damage conditions is much higher than that under no DNA damage (healthy cell) due to its increased production in response to DNA damage.
Furthermore, p21 level in high-level DNA damage is lower than that in low-level DNA damage (20-25% difference between the maximum levels) because p53 is used to trigger the apoptosis pathway for high-level DNA damage. In both DNA damage conditions, the effect of lowering CDK2 is initially insignificant on the p21 level that kept constant until CycE level increases closer to the G1/S transition (at around 1500 time steps in Fig.2 ) for all four CDK2 levels. Then, the reduced CDK2 level comes into effect influencing the behaviour of p21. Increased CycE production in the cell cycle requires, more CDK2 for binding to CycE to form CycE/CDK2 complex, and this complex can further associate with p21 to form the triple complex p21/CycE/CDK2. This process results in a dramatic decrease in p21 level; however, p21 level increases at the end of G1 phase because CycE level decreases in the S phase thereby releasing more p21 in the cell cycle transition. Reducing CDK2 levels results in producing less CycE/CDK2 to associate with p21 thereby increasing the concentration of p21. For this reason, p21 level in the cell cycle is the highest for 50% reduction of CDK2 levels compared to the two smaller reductions.
Now we turn to investigating the behaviour of CDK2 in response to increased levels of its CKIs. First we analyse the effect of degradation rate of CKIs on CDK2
concentration by decreasing their corresponding kinetic parameters in the mathematical model. According to the model results presented in Fig.3 , there is an effect of adjusting the degradation rate of p21 on the variation of CDK2 for the two DNA damage situations. However, the variation of the degradation rate of p27 and p16 makes little or no effect on CDK2 levels under these two DNA damage conditions (not shown). According to Fig.3 , the influence of the degradation rate of p21 on CDK2 is predominant during the G1/S transition. The reason is that the concentration of CDK2 is mainly controlled by CycE in G1/S transition. For example, at the beginning of G1 in the cell cycle of a healthy cell, the CycE level is kept at a low level which keeps CDK2 and CycE in balance. However, the concentration of CycE significantly increases during G1/S transition, which results in an imbalance between CycE and CDK2. Therefore, more CDK2 is required to associate with CycE.
In the DNA damage situation, p21 is activated in the G1 phase and it plays an important role in reducing CDK2 levels. The reason is that increased p21 binds to CycE/CDK2 complex to inhibit E2F, which in turn inhibits CycE levels, leading to delayed and slower production of CycE under damage conditions compared to the healthy condition. This reduces the need for as high CDK2 levels as in the healthy condition. Therefore, lower p21 degradation rates leads to higher CDK2 levels as indicated in Fig.3 . Higher levels of free CDK2 indicate the presence of low CycE levels giving rise to further delays in the progression of these cells through G1/S transition. According to Fig3, there is a small difference in the free CKD2 levels between the low-level and high-level DNA damage conditions due to the difference in the amount of p21 levels between the two conditions. Although there is a significant difference in the amount of p21 in the two different DNA-damage situations shown in Fig.2 , only a part of p21 can bind to CycE/CDK2-P or CycA/CDK2-P to control free CKD2 in cells because the increased CycE/CDK2-P and CycA/CDK2-P near G1/S transition can promote the degradation of p27, resulting in releasing more free
CycD/CDK4/6 that creates a competition for p21 binding with these two complex proteins (CycE/CDK2-P and CycA/CDK2-P).
Next, we focus on the effect of production rate of CKIs on CDK2 levels. Results
revealed by the mathematical model show that the production rate of CKIs has little or no effect on the CDK2 concentration for low-level and high-level DNA damage situations (not shown). in the whole region of G1/S transition.
Effectiveness of CKIs alone and simultaneous variation of CDK2/CKIs on lowering senescence bar
Relying on the outcome of the analysis of the relationship between CDK2 and CKIs, the focus of this step is to analyse the percentage of damaged cells that can be prevented from passing G1/S by further lowering the senescence threshold through regulating the CKIs and the combination of CDK2 and CKIs. The value of β in response to individually changing CDK2 or CKIs (in our case, p21 degradation rate and p27 initial condition) based on the behavior of E2F for parameter range of 30% ± is shown Fig. 5 which indicates that the increase in p27 initial condition makes the most significant contribution to reducing the probability of a damaged cell passing the G1/S for the two DNA-damage situations, followed by the reduced CDK2 level and the decreased p21 degradation rate, with the difference between the latter two being After the analysis of separately changing CDK2 or CKIs, we also focus on the effect of the combination of CDK2 and CKIs on β for two different levels of their change (30% and 50%). For example, simultaneously reducing CDK2 and p21 degradation rate as well as simultaneously reducing CDK2 and increasing p27 initial condition. According to the behavior of CycE for parameter range 30% ± (see Fig.7 and 8 ), we get similar results to those revealed by E2F, except for the β for the case of individually changing CDK2 or CKIs. In this case, reduction in CDK2 level makes a larger contribution to decreasing the percentage of damaged cells passing G1/S checkpoint than increase in p27 initial condition The values of β in response to changing CDK2 or CKIS separately as well as in combination based on the PDF of the two biomarkers for parameter range 50% ± can be found in the Supplementary Materials. Results for the parameter range 50% ± show similar trends for the behaviour of E2F and CycE as those revealed from parameter range 30% ± ; however, the percentage of the damaged cell passing G1/S under 50% ± parameter range is larger than that under 30% ± parameter range.
Conclusions
We have demonstrated that the mathematical model incorporating G1/S checkpoint pathway and DNA damage signal transduction pathway supports the possibility of lowering the bar for cellular senescence. It shows that CDK2 and its CKIs (p21 and p27) can be targets for achieving this. Specifically, analysing the time to reach the maximum (PT) concentration of E2F and CycE as two critical proteins in the G1/S transition, we demonstrated that lowering CDK2 levels influences the PT of these critical proteins, which we used to assess the change in the probability β of a damaged cell passing the G1/S checkpoint. Then we investigated the relationship between CDK2 and its CKIs for the two DNA-damage signals as well as the effects of CKIs and the combination of CDK2 and CKIs on the probability of a damaged cell passing the check point.
The results of β based on the PDF of PT of the chosen biomarkers (E2F and CycE)
for three reduced CDK2 levels (CDK2-10%, CDK2-30% and CDK2-50%) under two DNA-damage conditions reveal that reducing CDK2 levels can reduce the percentage of damage cells passing the G1/S checkpoint, indicating that CDK2 can be a target for In the search for other effective ways to bring forward cellular senescence, the model revealed some useful relationships between CDK2 and its CKIs (in terms of production rate, degradation rate and initial conditions) under DNA-damage situations.
Specifically, results revealed that CDK2 has a strong relationship with p21
(degradation rate) and p27 (initial condition). Additionally, the model revealed the spectrum of the behaviour of CDK2 in terms of varying levels of p21 and p27 in the whole region of G1/S transition. This gives us some insights into how to further trigger cellular senescence in oncogenically primed cells through targeting these key CKIs individually or a combination of lowered CDK2 levels and reduced degradation rate of p21, and/or increased initial level of p27 before cells start proliferation.
Individually, p27 appeared to be more than twice as effective as p21 in resisting damaged cells passing the G1/S, based on both E2F and CycE behaviour. The behaviour of the two biomarkers revealed a small discrepancy in the effect of individually varying CDK2 level in that CDK2 is slightly more effective than even p27 according to CycE, making CDK2 the most effective individual target.
Nonetheless, both E2F and CycE showed that the combination of CDK2 and p27 is much more effective than that of CDK2 and p21, with 50% change in the former arresting almost all damaged cells before passing G1/S.
Results revealed so far from the mathematical model are consistent with the current knowledge of biology and experimental observations, and adds a detailed view of the efficacy of important targets for lowering senescence bar. More importantly, the model investigation of the effect of the combination of CDK2 and CKIs on the percentage of damaged cells passing the G1/S transition may give us some ideas to explore a powerful and effective way to further trigger cellular senescence in oncogenically primed cells. Biologist may wish to verify these findings to validate the effectiveness of the targets in a practical setting. We hope that further analysis will help us better understand cellular senescence for exploiting its mechanisms for an effective cancer treatment by lowering its threshold.
Methods Summary
In this study, the developed mathematical model is used to investigate the behaviour of PT of the chosen biomarkers (E2F and CycE) of the G1/S transition in response to CDK2-deficient situations. The purpose of this is to confirm whether the developed model can highlight cellular senescence in response to lowering the critical point (CDK2 inhibition) for senescence. We use the same model and the parameter set as our earlier study 3 (healthy cell) is also shown in the figure).
Fig.5
The probability β of a damage cell passing G1/S checkpoint in response to only changing CDK2 or CKIs (i.e. p21 degradation rate and p27 initial condition) for three different ranges of normal, 30% and 50% -specifically, CKD2 or p21 degradation rate reduced or p27 initial condition increased by 0%, 30% and 50%, respectively -using the behavior of E2F for parameter range 30% ± under different DNA-damage conditions: low level DNA-damage and high level DNA-damage.
Fig.6
The probability β of a damaged cell passing G1/S in response to simultaneously changing CDK2 and CKIs (i.e. p21 degradation rate and p27 initial condition) for three different ranges of normal, 30% and 50% -specifically, CKD2 and p21 degradation rate both reduced by 0%, 30% and 50%, respectively, or CDK2 reduced and p27 initial condition increased by 0%, 30% and 50%, respectively-using the behavior of E2F for parameter range 30% ± under two different DNA-damage conditions.
Fig.7
The probability β of a damaged cell passing G1/S checkpoint for only changing CDK2 or CKIs (i.e. p21 degradation rate and p27 initial condition) for three different ranges of normal, 30% and 50% -specifically, CKD2 or p21 degradation rate reduced, or p27 initial condition increased by 0%, 30% and 50%, respectively -using the behavior of CycE for parameter range 30% ± under different DNA-damage conditions: low level DNA-damage and high level DNA-damage Fig.8 The probability β of a damaged cell passing G1/S in response to simultaneously changing CDK2 and CKIs (i.e. p21 degradation rate and p27 initial condition) for three different ranges of normal, 30% and 50% -specifically, CKD2 and p21 degradation rate both reduced by 0%, 30% and 50%, respectively, or CDK2 reduced and p27 initial condition increased by 0%, 30% and 50%, respectively -using the behavior of CycE for parameter range 30% ± under two different DNA-damage conditions.
